LianBio Other Nonoperating Income (Expense)
LianBio (LIANY) reported Other Nonoperating Income (Expense) of $141.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2023-11-13
- LianBio other nonoperating income (expense) for the quarter ending 2023-09-30 was $141.00K, a 88.75% decline year-over-year.
- LianBio other nonoperating income (expense) for the quarter ending 2023-06-30 was $869.00K, a 328.08% increase year-over-year.
- LianBio other nonoperating income (expense) for the quarter ending 2023-03-31 was -$44.00K, a 110.55% decline year-over-year.
- LianBio other nonoperating income (expense) for the quarter ending 2022-12-31 was $8.54M.
- LianBio other nonoperating income (expense) for fiscal 2022 was $10.41M.
- LianBio other nonoperating income (expense) for fiscal 2021 was -$455.00K, a 469.92% decline from fiscal 2020.
- LianBio other nonoperating income (expense) for fiscal 2020 was $123.00K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2023-09-30 | $141.00K 10-Q · filed 2023-11-13 | $1.01M derived: sum of 2 quarters · filed 2023-11-13 | $966.00K 10-Q · filed 2023-11-13 | $9.50M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | $869.00K 10-Q · filed 2023-08-14 | $825.00K 10-Q · filed 2023-08-14 | $9.36M derived: sum of 3 quarters · filed 2023-08-14 | $10.61M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | -$44.00K 10-Q · filed 2023-05-11 | $8.49M derived: sum of 2 quarters · filed 2023-05-11 | $9.74M derived: sum of 3 quarters · filed 2023-11-13 | $9.95M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | $8.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $9.79M derived: sum of 2 quarters · filed 2023-11-13 | $9.99M derived: sum of 3 quarters · filed 2023-11-13 | $10.41M 10-K · filed 2023-03-28 |
| 2022-09-30 | $1.25M 10-Q · filed 2023-11-13 | $1.46M derived: sum of 2 quarters · filed 2023-11-13 | $1.87M 10-Q · filed 2023-11-13 | $1.61M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $203.00K 10-Q · filed 2023-08-14 | $620.00K 10-Q · filed 2023-08-14 | $354.00K derived: sum of 3 quarters · filed 2023-08-14 | $357.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $417.00K 10-Q · filed 2023-05-11 | $151.00K derived: sum of 2 quarters · filed 2023-05-11 | $154.00K derived: sum of 3 quarters · filed 2023-05-11 | $86.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$266.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$263.00K derived: sum of 2 quarters · filed 2023-03-28 | -$331.00K derived: sum of 3 quarters · filed 2023-03-28 | -$455.00K 10-K · filed 2023-03-28 |
| 2021-09-30 | $3.00K 10-Q · filed 2022-11-10 | -$65.00K derived: sum of 2 quarters · filed 2022-11-10 | -$189.00K 10-Q · filed 2022-11-10 | -$147.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$68.00K 10-Q · filed 2022-08-11 | -$192.00K 10-Q · filed 2022-08-11 | -$150.00K derived: sum of 3 quarters · filed 2022-08-11 | -$51.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$124.00K 10-Q · filed 2022-05-12 | -$82.00K derived: sum of 2 quarters · filed 2022-05-12 | $17.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $42.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | $141.00K derived: sum of 2 quarters · filed 2022-03-31 | $123.00K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $99.00K 10-Q/A · filed 2022-01-10 | $81.00K 10-Q/A · filed 2022-01-10 |